These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AudioEye, Inc
.
|
|
Delaware
|
20-2939845 |
|
||||||||
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|||||||||
| 9070 South Rita Road, Suite 1450, Tucson, Arizona | 85747 | |||||||||
|
(Address of principal executive offices)
|
(Zip Code)
|
|||||||||
|
Registrant’s telephone number, including area code:
|
866-331-5324 |
|
|||||||||
|
Large accelerated filer
|
o |
Accelerated filer
|
o |
|
Non-accelerated filer
|
o |
Smaller reporting company
|
x |
|
Page
|
||
|
|
||
|
1
|
||
|
|
||
|
2
|
||
|
|
|
|
|
3
|
||
|
|
||
|
4
|
||
|
|
||
|
5
|
||
|
|
||
|
10
|
||
|
14
|
||
|
14
|
||
|
|
||
|
1
5
|
||
|
15
|
||
|
15
|
||
|
15
|
||
|
15
|
||
|
15
|
||
|
16
|
||
|
|
17 |
|
AUDIOEYE, INC.
|
||||||||
|
(UNAUDITED)
|
||||||||
|
March 31, 2013
|
December 31, 2012
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash
|
$ | 93,420 | $ | 11,710 | ||||
|
Accounts receivable, net
|
13,000 | 16,256 | ||||||
|
Related party receivables
|
16,125 | 16,125 | ||||||
|
Marketable securities
|
21,000 | 30,000 | ||||||
|
Total Current Assets
|
143,545 | 74,091 | ||||||
|
Property and equipment, net
|
6,244 | 7,043 | ||||||
|
Intangible assets, net
|
3,361,264 | 3,448,221 | ||||||
|
Goodwill
|
700,528 | 700,528 | ||||||
|
Total Assets
|
4,211,581 | $ | 4,229,883 | |||||
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 456,202 | $ | 498,365 | ||||
|
Deferred Revenue
|
44,443 | 54,823 | ||||||
|
Notes and loans payable-current
|
24,000 | 1,466,700 | ||||||
|
Related party payable
|
— | 829,418 | ||||||
|
Total Current Liabilities
|
524,645 | 2,849,306 | ||||||
|
Long term liabilities
|
||||||||
|
Notes and loans payable-long term
|
91,800 | 97,800 | ||||||
|
Related party loans
|
10,000 | 10,000 | ||||||
|
Total Long term Liabilities
|
101,800 | 107,800 | ||||||
|
Total Liabilities
|
626,445 | 2,957,106 | ||||||
|
STOCKHOLDERS’ DEFICIT
|
||||||||
|
Common stock, $0.00001 par value, 100,000,000 shares authorized, 43,062,199 and 35,192,045 issued and outstanding, as of March 31, 2013 and December 31, 2012,
respectively
|
431 | 352 | ||||||
|
Additional paid in capital
|
4,491,413 | 1,783,047 | ||||||
|
Accumulated deficit
|
(906,708 | ) | (510,622 | ) | ||||
|
Total Stockholders’ Deficit
|
3,585,136 | 1,272,777 | ||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
$ | 4,211,581 | $ | 4,229,883 | ||||
|
See Notes to Unaudited Consolidated Financial Statements
|
||||||||
|
AUDIOEYE, INC.
|
||||||||
|
(UNAUDITED)
|
||||||||
|
For the Three Months ended
|
||||||||
|
March 31, 2013
|
March 31, 2012
|
|||||||
|
Revenue
|
$ | 224,297 | $ | 14,255 | ||||
|
Revenue from related party
|
— | 750 | ||||||
|
Cost of revenues
|
45,023 | 89,735 | ||||||
|
Gross Profit
|
179,274 | (74,730 | ) | |||||
|
General and administrative expenses
|
541,393 | 172,846 | ||||||
|
Operating income (loss)
|
(362,119 | ) | (247,576 | ) | ||||
|
Other income (expense)
|
||||||||
|
Unrealized gain (loss) on marketable securities
|
(9,000 | ) | 25,500 | |||||
|
Interest expense
|
(24,967 | ) | (3,536 | ) | ||||
|
Total other income (expense)
|
(33,967 | ) | 21,964 | |||||
|
Net (loss)
|
$ | (396,086 | ) | $ | (225,612 | ) | ||
|
Net (loss) per common share - basic and diluted
|
$ | (0.01 | ) | $ | (0.01 | ) | ||
|
Weighted average common shares outstanding -
basic and diluted
|
36,965,057 | 30,005,185 | ||||||
|
See Notes to Unaudited Consolidated Financial Statements
|
||||||||
|
For the Three Months ended
|
||||||||
|
March 31, 2013
|
March 31, 2012
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net (loss)
|
$ | (396,086 | ) | $ | (225,612 | ) | ||
|
Adjustments to reconcile net loss to net cash provided by
(used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
89,593 | 3,455 | ||||||
|
Stock, option and warrant expense
|
169,756 | — | ||||||
|
Unrealized (gain) loss on investments
|
9,000 | (25,500 | ) | |||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
3,256 | (11,877 | ) | |||||
|
Related party receivable
|
— | (750 | ) | |||||
|
Other assets
|
— | (3,271 | ) | |||||
|
Accounts payable and accruals
|
70,071 | (28,782 | ) | |||||
|
Deferred revenue
|
(10,380 | ) | 13,370 | |||||
|
Related party payables
|
— | 79,615 | ||||||
|
Net cash (used in) operating activities
|
(64,790 | ) | (199,352 | ) | ||||
|
Cash Flows from financing activities:
|
||||||||
|
Repayment of note payable
|
(206,000 | ) | — | |||||
|
Proceeds from third party loans
|
352,500 | 244,000 | ||||||
|
Net cash provided by financing activities
|
146,500 | 244,000 | ||||||
|
Increase (decrease) in cash
|
81,710 | 44,648 | ||||||
|
Cash - beginning of period
|
11,710 | 32,156 | ||||||
|
Cash - end of period
|
$ | 93,420 | $ | 76,804 | ||||
|
NON-CASH FINANCING ACTIVITIES
|
||||||||
|
Common stock issued for conversion of debt
|
$ | 1,692,932 | $ | — | ||||
|
Warrants issued for related party loans
|
829,418 | — | ||||||
|
Common Stock Issued to CMGO for debt repayment
|
241,339 | — | ||||||
|
Patents capitalized in accounts payable
|
1,837 | 3,470 | ||||||
|
Accounts payable converted into debt
|
30,000 | — | ||||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||
|
Interest paid
|
$ | 24,967 | $ | — | ||||
|
Income taxes paid
|
$ | — | $ | — | ||||
|
See Notes to Unaudited Consolidated Financial Statements
|
||||||||
|
Outstanding and Exercisable Options
|
||||||||||||||||||||||
|
Remaining
|
Exercise Price
|
Weighted
|
||||||||||||||||||||
|
Number of
|
Contractual Life
|
times Number
|
Average
|
Intrinsic
|
||||||||||||||||||
| Exercise Price |
Shares
|
(in years)
|
of Shares
|
Exercise Price
|
Value
|
|||||||||||||||||
| $ |
0.25
|
2,820,000 | 5 | $ | 705,000 | $ | 0.25 | $ | 0 | |||||||||||||
| 2,820,000 | $ | 705,050 | $ | 0.25 | 0 | |||||||||||||||||
|
Purchase Price Allocation
|
|||||||||
|
Purchase Price:
|
Cash
|
$ | 1,125,000 | ||||||
|
1,500,000 shares of AEAC stock
|
375,000 | $ | 1,500,000 | ||||||
|
Less: Net Assets (deficit)
|
2,752,342 | * | |||||||
|
Less: Identifiable Intangibles - Patents
|
(3,551,814 | ) | |||||||
|
Goodwill
|
$ | 700,528 | |||||||
|
Net Assets (deficit)
|
||||
|
Book Value
|
||||
|
at 08/17/12
|
||||
|
Current Assets
|
$
|
109,521
|
||
|
Property, Plant & Equipment, net
|
7,688
|
|||
|
Patents
|
—
|
|||
|
Current Liabilities
|
(1,517,724
|
)
|
||
|
L/T Liabilities
|
(1,351,827
|
)
|
||
|
Contingent Liabilities (Note 2)
|
—
|
|||
|
Net Assets (deficit)
|
$
|
(2,752,342
|
)*
|
|
|
Assets
|
||||
|
Cash
|
4,593 | |||
|
Intangible Assets
|
3,551,814 | |||
|
Goodwill
|
700,528 | |||
|
Total Assets
|
4,256,935 | |||
|
Liabilities
|
||||
|
Accounts payable and accrued expenses
|
117,162 | |||
|
Net Assets
|
4,139,773 | |||
|
March 31,
|
December 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Patents
|
$ | 3,553,651 | $ | 3,553,651 | ||||
|
Accumulated Amortization
|
(192,387 | ) | (105,430 | ) | ||||
|
Intangible Assets, Net
|
$ | 3,361,264 | $ | 3,448,221 | ||||
|
Results of Operations
|
Three Months Ended
March 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Revenue
|
$ | 224,297 | $ | 14,255 | ||||
|
Revenue from related party
|
— | 750 | ||||||
|
Cost of Sales
|
45,023 | 89,735 | ||||||
|
Gross profit (loss)
|
179,274 | (74,730 | ) | |||||
|
General and administrative expenses
|
541,393 | 172,846 | ||||||
|
Patent impairment expense
|
— | — | ||||||
|
Operating (loss)
|
(362,119 | ) | (247,576 | ) | ||||
|
Unrealized gain (loss) on marketable securities
|
(9,000 | ) | 25,500 | |||||
|
Loss attributable to non-controlling interest
|
— | — | ||||||
|
Interest expense
|
(24,967 | ) | (3,536 | ) | ||||
|
Net (loss)
|
$ | (396,086 | ) | $ | (225,612 | ) | ||
|
Net (loss) per Weighted average common shares outstanding – basic and diluted
|
$ | (0.01 | ) | $ | (0.01 | ) | ||
|
Working Capital
|
|||||||
|
At March 31,
|
At December 31,
|
||||||
|
2013
|
2012
|
||||||
|
Current Assets
|
$ | 143,545 | $ | 74,091 | |||
|
Current Liabilities
|
524,645 | 2,849,306 | |||||
|
Working Capital (Deficit)
|
$ | (381,100 | ) | $ | (2,775,215 | ) | |
|
Cash Flows
|
For the three months ended
|
|||||||
|
March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Net Cash (Used in) Operating Activities
|
$ | (64,790 | ) | $ | (199,352 | ) | ||
|
Net Cash Provided by Financing Activities
|
146,500 | 244,000 | ||||||
|
Increase (Decrease) in Cash
|
$ | 81,710 | $ | 44,648 | ||||
|
Exhibit
No.
|
Description
|
|
|
10.1
|
Agreement and Plan of Merger dated as of March 22, 2013 between AudioEye, Inc. and AudioEye Acquisition Corporation (1)
|
|
|
31.1*
|
||
|
31.2*
|
||
|
32.1*
|
||
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document | |
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
(1)
|
Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on March 27, 2013.
|
| AUDIOEYE, INC. | ||
| By: |
/
s/ Nathaniel Bradley
|
|
|
Nathaniel Bradley
|
||
|
Chief Executive Officer and President
|
||
| By: |
/
s/ Edward O’Donnell
|
|
|
Edward O’Donnell
|
||
|
Chief Financial Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|